Main Article Content

Sarad Pawar Naik Bukke
Tamma Avinash Reddy
Narayana Goruntla
Hussaini Bello


Tamoxifen, Solid dispersion tablets, Development, Characterisation


The present study was carried out on Tamoxifen by employing solid dispersion technique. The λmax of phosphate buffer pH 6.8 of Tamoxifen were found to be at 276 nm. The pure drug the optimised Solid dispersion formulations were subjected to FTIR studies. The results were showed that there is no interaction between the drug and excipients. The micrometric properties of blend of Tamoxifen soild dispersion were characterized with respect to Angle of repose, bulk density, tapped density, Carr’s index and Hausner’s ratio. Angle of repose was less than 280, Carr’s index values were 10 to 17 for the pre compression blend of all the batches indicating good to fair flowability and compressibility. Hausner’s ratio was less than 1.2 for all the batches indicating good flow properties. All the tablets of different batches complied with the official requirement of weight variation as their weight variation passes the limits. The hardness of the tablets ranged from 2 to 3 kg/cm2 and the friability values were less than 1% indicating that the tablets were compact and hard. The thickness of the tablets ranged between 3.1 to 3.8 mm. All the formulations satisfied the content of the drug as they contained 96-100% of Tamoxifen and good uniformity in drug content was observed. Thus, all the physical attributes of the prepared tablets were found to be practically within control limits.The dissolution profile of Tamoxifen tablets was compared between solid dispersion tablets. The Tamoxifen solid dispersion tablets showed better release in phosphate buffer pH 6.8, in that F2 showed good drug release i.e., 99.89 at 15 minutes. F2 formulation was taken as optimised formulation.

Abstract 106 | pdf Downloads 42


1. Kumar VD, Sharma I, and Sharma V: A comprehensive review on fast dissolving tablet technology, Journal of Applied Pharmaceutical Sciences 2011; 05(01):50-58.
2. Kaur T, Gill B, Kumar S, Gupta GD: Mouth Dissolving Tablets: A Novel Approach to Drug Delivery. International Journal of Current Pharmaceutical Research 2011; 03(1):1-7.
3. Arya A, Chandra A: Fast drug delivery system: A review. Scholars Research Library 2010; 02(02):350-361.
4. Ghosh T, Ghosh A, Prasad D: A review on new generation orodispersible tablets and its future prospective. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 03(01):1-7.
5. Deshpande KB, Ganesh NS: Orodispersible tablets: An overview of formulation and technology. International Journal of Pharma and Bio sciences 2011; 02(01):726-734.
6. Lindgren S, Janzon L. Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population. Dysphagia. 1991; 6: 187–192. doi:10.1007/BF02493524
7. Avery SW, Dellarosa DM. Approaches to treating dysphagia patients with brain injury. Am J Occup Ther. 1994; 48: 235–239. PMid:8178917
8. Gisel EG. Oral motor skills following sensorimotor intervention the moderately eating impaired child with cerebral palsy. Dysphagia. 1994; 9: 180–192. doi:10.1007/BF00341263
9. Andersen O, Zweidorff OK, Hjelde T, Rødland EA. [Problems when swallowing tablets. A questionnaire study from general practice]. Tidsskr Nor Laegeforen. 1995; 115: 947–949. PMid:7709385
10. Kahrilas PJ. Anatomy, physiology and pathophysiolo dysphagia. Acta Otorhinolaryngol Belg. 1994; 48: 97–117. PMid:8209687
11. FDA Approved Drug Products: Tamoxifen Oral Solution
12. Jordan VC: Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. Br J Pharmacol. 1993 Oct;110(2):507-17. (PubMed ID 8242225)